Get the Stockscreener App
8.55
0.47%
0.04
After Hours:
8.50
-0.05
-0.58%
Adicet Bio Inc stock is traded at $8.55, with a volume of 112.91K.
It is up +0.47% in the last 24 hours and up +23.91% over the past month.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
See More
Previous Close:
$8.51
Open:
$8.51
24h Volume:
112.91K
Relative Volume:
0.79
Market Cap:
$79.93M
Revenue:
$24.99M
Net Income/Loss:
$-116.80M
P/E Ratio:
-0.6355
EPS:
-13.4543
Net Cash Flow:
$-96.98M
1W Performance:
+12.06%
1M Performance:
+23.91%
6M Performance:
-21.04%
1Y Performance:
-11.35%
1-Day Range:
$8.37
$8.765
1-Week Range:
$7.45
$8.88
52-Week Range:
$6.01
$17.44
Adicet Bio Inc Stock (ACET) Company Profile
Name
Adicet Bio Inc
Sector
Industry
Phone
617-482-2333
Address
131 DARTMOUTH STREET, BOSTON
Compare ACET vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
8.55 | 79.55M | 24.99M | -116.80M | -96.98M | -13.45 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-24 | Resumed | Guggenheim | Buy |
| Sep-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-27-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-01-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Mar-31-22 | Initiated | SMBC Nikko | Outperform |
| Mar-08-22 | Initiated | Truist | Buy |
| Mar-04-22 | Initiated | Jefferies | Buy |
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-23-21 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Canaccord Genuity | Buy |
| Apr-08-21 | Initiated | Guggenheim | Buy |
| Nov-04-20 | Initiated | B. Riley Securities | Buy |
| Oct-27-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-20 | Initiated | Wedbush | Outperform |
View All
Adicet Bio Inc Stock (ACET) Latest News
Adicet Bio (NASDAQ:ACET) Now Covered by Analysts at Jefferies Financial Group - MarketBeat
Jefferies Initiates Adicet Bio(ACET.US) With Buy Rating, Announces Target Price $19 - Moomoo
Jefferies initiates Adicet Bio stock with buy rating, $19 target By Investing.com - Investing.com Australia
Johnson & Johnson Sells 341,693 Shares of Adicet Bio, Inc. $ACET - MarketBeat
Adicet Bio (NASDAQ:ACET) Rating Increased to Sell at Wall Street Zen - MarketBeat
Adicet Bio Inc expected to post a loss of $3.11 a shareEarnings Preview - TradingView
ACET Forecast, Price Target & Analyst Ratings | ADICET BIO INC (NASDAQ:ACET) - ChartMill
Adicet Bio (ACET) upgraded to buy: Here's why - MSN
RA Capital (NASDAQ: ACET) exchanges 250K Adicet Bio shares for pre-funded warrant - Stock Titan
Adicet Bio (ACET) sets 2026 virtual meeting, director elections and Say-on-Pay vote - Stock Titan
Adicet Bio Issues Pre-Funded Warrant in Equity Exchange - TipRanks
Adicet Bio (NASDAQ: ACET) issues 250,000-share pre-funded warrant in exchange deal - Stock Titan
Adicet Bio (ACET) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
ACET Stock Price, Quote & Chart | ADICET BIO INC (NASDAQ:ACET) - ChartMill
Canaccord Genuity Sticks to Their Buy Rating for Adicet Bio (ACET) - The Globe and Mail
Adicet Bio (ACET) Innovation Pipeline | Adicet Bio Inc. posts wider loss vs estimates, no revenueTrading Community - Cổng thông tin điện tử Tỉnh Sơn La
CCORF Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Adicet Bio Inc. posts wider loss vs estimates, no revenueReal Time Stock Idea Network - Xã Vĩnh Công
Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving AverageHere's Why - MarketBeat
RA CAPITAL MANAGEMENT, L.P. Acquires Shares in Adicet Bio Inc - GuruFocus
Orbimed Advisors LLC Reduces Stake in Adicet Bio Inc - GuruFocus
Adicet Bio (ACET) price target decreased by 13.82% to 54.06 - MSN
Ra Capital buys Adicet Bio (ACET) shares worth $1.6 million By Investing.com - Investing.com Australia
Adicet Bio (NASDAQ:ACET) Major Shareholder Purchases $535,472.28 in Stock - MarketBeat
Ra Capital Management, L.P. Buys 74,751 Shares of Adicet Bio (NASDAQ:ACET) Stock - MarketBeat
Ra Capital buys Adicet Bio (ACET) shares worth $1.6 million - Investing.com
RA Capital and partners disclose stake in Adicet Bio (NASDAQ: ACET) - Stock Titan
RA Capital boosts Adicet Bio (ACET) stake with open-market share purchases - Stock Titan
RA Capital details Adicet Bio (ACET) pre-funded warrant and share stake - Stock Titan
OrbiMed cuts Adicet Bio (ACET) holdings to 8.8% after share sales - Stock Titan
OrbiMed Advisors sells Adicet Bio (ACET) stock worth $674,847 By Investing.com - Investing.com Australia
OrbiMed Advisors sells Adicet Bio (ACET) stock worth $674,847 - Investing.com
OrbiMed funds trim Adicet Bio (ACET) stake with 104,658-share sale - Stock Titan
[144] Adicet Bio, Inc. SEC Filing - Stock Titan
Trade Report: What is the earnings history of Adicet Bio Inc2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Quarterly Earnings: Can Adicet Bio Inc continue delivering strong returns2026 Closing Moves & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell? - Defense World
JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $20 - Moomoo
ACET PE Ratio & Valuation, Is ACET Overvalued - Intellectia AI
Analyst Calls: What analysts say about Adicet Bio Inc stockMarket Sentiment Review & AI Driven Stock Price Forecasts - baoquankhu1.vn
Inflation Data: Can Adicet Bio Inc continue delivering strong returnsEarnings Recap Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Adicet Bio Inc. R (1IJ.F) options chain - Yahoo Finance UK
ACET Technical Analysis & Stock Price Forecast - Intellectia AI
ACET SEC FilingsAdicet Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Buybacks Report: Is Adicet Bio Inc on track to beat earningsEarnings Risk Summary & Fast Moving Stock Trade Plans - baoquankhu1.vn
Aug Setups: What is the earnings history of Adicet Bio IncWeekly Trade Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
Adicet Bio Inc Stock (ACET) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):